CERES, a retrospective study of patients with advanced renal cell carcinoma who received cabozantinib as part of the UK Managed Access Program: Baseline characteristics and clinical outcomes

Saved in:
Bibliographic Details
Published in:European urology open science (Online) 2020-11, Vol.21, p.S190-S191
Main Authors: Szabados, B., Michael, A., Powles, T., Fife, K., Klair, B., Perrot, V., Venugopal, B.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-1683
2666-1683
DOI:10.1016/S2666-1683(20)36237-6